Sharon L Gardner

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. ncbi Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors
    Sharon L Gardner
    Department of Pediatrics, New York University, New York, New York 10016, USA
    Pediatr Blood Cancer 51:235-40. 2008
  2. ncbi High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma
    Ira J Dunkel
    Memorial Sloan Kettering Cancer Center, Box 185, 1275 York Avenue, New York, NY 10065, USA
    Neuro Oncol 12:297-303. 2010
  3. ncbi Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma
    Ira J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pediatr Blood Cancer 55:55-9. 2010
  4. ncbi Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group
    Jonathan L Finlay
    The Children s Center for Cancer and Blood Diseases, Department of Pediatrics, Children s Hospital, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 51:806-11. 2008
  5. ncbi Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors
    Stephen A Sands
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Pediatr Blood Cancer 54:429-36. 2010
  6. ncbi The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors
    Aerang Kim
    New York University Medical Center, New York, New York, USA
    Pediatr Blood Cancer 51:768-73. 2008
  7. ncbi Application of stem cell transplant for brain tumors
    Sharon L Gardner
    New York University, New York, NY, USA
    Pediatr Transplant 8:28-32. 2004
  8. ncbi Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma
    Susan N Chi
    Division of Pediatric Oncology, New York University Medical Center, New York, NY, USA
    J Clin Oncol 22:4881-7. 2004
  9. ncbi High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors
    Alberto Broniscer
    Children's Cancer Group: New York University Medical Center, New York, NY, USA
    Pediatr Blood Cancer 42:261-7. 2004
  10. ncbi Preoperative chemotherapy to salvage the hand in a case of giant infantile hemangiopericytoma
    Lisa F Schneider
    Institute of Reconstructive Plastic Surgery and the Division of Pediatric Oncology, New York University Langone Medical Center, New York, NY 10016, USA
    J Hand Surg Am 35:995-8. 2010

Detail Information

Publications10

  1. ncbi Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors
    Sharon L Gardner
    Department of Pediatrics, New York University, New York, New York 10016, USA
    Pediatr Blood Cancer 51:235-40. 2008
    ..Historically, surgery and standard dose chemotherapy have resulted in a median survival of 8.5 months from diagnosis...
  2. ncbi High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma
    Ira J Dunkel
    Memorial Sloan Kettering Cancer Center, Box 185, 1275 York Avenue, New York, NY 10065, USA
    Neuro Oncol 12:297-303. 2010
    ..09). This retrieval strategy provides long-term EFS for some patients with previously irradiated recurrent medulloblastoma. The use of additional RT may be associated with better outcome...
  3. ncbi Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma
    Ira J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pediatr Blood Cancer 55:55-9. 2010
    ....
  4. ncbi Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group
    Jonathan L Finlay
    The Children s Center for Cancer and Blood Diseases, Department of Pediatrics, Children s Hospital, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 51:806-11. 2008
    ..Children and adolescents with malignant astrocytomas recurring after initial treatment have a dismal prognosis, with only rare patients surviving 1-year beyond recurrence. The purpose of this study was to attempt to improve their survival...
  5. ncbi Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors
    Stephen A Sands
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Pediatr Blood Cancer 54:429-36. 2010
    ..To evaluate the neuropsychological late effects amongst survivors treated on the Head Start II protocol between 1997 and 2003...
  6. ncbi The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors
    Aerang Kim
    New York University Medical Center, New York, New York, USA
    Pediatr Blood Cancer 51:768-73. 2008
    ....
  7. ncbi Application of stem cell transplant for brain tumors
    Sharon L Gardner
    New York University, New York, NY, USA
    Pediatr Transplant 8:28-32. 2004
    ..High dose chemotherapy with ASCR is a foundation upon which many different types of therapies can be built. Several possibilities include the use of anti-angiogenesis agents, monoclonal antibodies and biologic response modifiers...
  8. ncbi Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma
    Susan N Chi
    Division of Pediatric Oncology, New York University Medical Center, New York, NY, USA
    J Clin Oncol 22:4881-7. 2004
    ..To evaluate the feasibility of and response rate to an intensified induction chemotherapy regimen for young children with newly diagnosed high-risk or disseminated medulloblastomas...
  9. ncbi High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors
    Alberto Broniscer
    Children's Cancer Group: New York University Medical Center, New York, NY, USA
    Pediatr Blood Cancer 42:261-7. 2004
    ..006 and 0.01, respectively). CONCLUSIONS: Patients with recurrent cortical PNETs can be cured with this strategy. Surgical debulking before, and irradiation after HDC play an important role in treatment success...
  10. ncbi Preoperative chemotherapy to salvage the hand in a case of giant infantile hemangiopericytoma
    Lisa F Schneider
    Institute of Reconstructive Plastic Surgery and the Division of Pediatric Oncology, New York University Langone Medical Center, New York, NY 10016, USA
    J Hand Surg Am 35:995-8. 2010
    ..Chemotherapy resulted in a decrease in tumor size, allowing for salvage of most of the hand and fingers. Preoperative chemotherapy should be considered in the care of HPC tumors involving the upper extremity in children...